Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new Revision: v3.3.3 appears in the footer, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe page history shows the addition of revision v3.3.2 and the removal of revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding/operating status notice from the page; this does not affect study data or the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedThe new screenshot shows the same version history and content as the old screenshot, with only minor visual formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.SummaryDifference10%

- Check105 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.